Transforming genes in chronic myelogenous leukemia.
AUTOR(ES)
Liu, E
RESUMO
Chronic myelogenous leukemia (CML) is a hematopoietic malignancy characterized by an indolent chronic phase that invariably leads to a "blast crisis" indistinguishable from acute leukemia. Using a sensitive assay based on gene transfer and tumorigenesis, we sought evidence that damage to protooncogenes might figure in the progression from the chronic to the blast phase of CML. Seven of the 12 patients with CML examined in this manner harbored transforming genes. Mutations in RAS protooncogenes were detected in the leukemic cells from 1 of 6 chronic-phase patients, and 3 of 6 blast-crisis patients. In addition, a presently unidentified transforming gene (neither RAS nor RAF) was detected in 1 patient with chronic phase and 1 with blast crisis. Our data indicate that mutations in RAS genes may play diverse roles in the pathogenesis of CML.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=279899Documentos Relacionados
- An 8-kilobase abl RNA transcript in chronic myelogenous leukemia.
- Blast crisis in a murine model of chronic myelogenous leukemia.
- T cells and probably B cells arise from the malignant clone in chronic myelogenous leukemia.
- Progressive de novo DNA methylation at the bcr-abl locus in the course of chronic myelogenous leukemia.
- Cytotoxic T cell response against the chimeric p210 BCR-ABL protein in patients with chronic myelogenous leukemia.